Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer

Santosh Renuse(AstraZeneca (United States)), Akhilesh Pandey(Mayo Clinic)

Cancers

July 7, 2021

10.3390/cancers13143404

Cited by 6

Related Papers

A draft map of the human proteome

|Nature|2014|2.3k

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

|Cell|2016|1.1k

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

|Cell|2019|849

Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database

|PROTEOMICS|2005|792

NetPath: a public resource of curated signal transduction pathways

|Genome biology|2010|532